"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Bacteriostatic Saline Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Bacteriostatic Water (bacteriostatic nacl) for Injection is a preparation is used only for diluting or dissolving drugs for intravenous, intramuscular, or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered. This medication is available in generic form. Common side effects include fever, tenderness, abscess or infection at the injection site, or blood clot or inflammation around the site of injection.
Your doctor will determine the proper dose of bacteriostatic water to use to dissolve or dilute a drug depending on the concentration, dose, and route of administration, according to manufacturer's instructions. Bacteriostatic water may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, bacteriostatic water should be used only if prescribed. Consult your doctor before breastfeeding.
Our Bacteriostatic Water (bacteriostatic nacl) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Bacteriostatic Saline FDA Prescribing Information: Side Effects
Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate counter-measures, and if possible, retrieve and save the remainder of the unused vehicle for examination.
Although adverse reactions to intravenous, intramuscular or subcutaneous injection of 0.9% benzyl alcohol are not known to occur in man, experimental studies of small volume parenteral preparations containing 0.9% benzyl alcohol in several species of animals have indicated that an estimated intravenous dose up to 30 mL may be safely given to an adult without toxic effects. Administration of an estimated 9 mL to a 6 kg infant is potentially capable of producing blood pressure changes.
Read the entire FDA prescribing information for Bacteriostatic Saline (Bacteriostatic NaCl)
Additional Bacteriostatic Saline Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.